VX14-661-110: A Phase 3, Open-label, Rollover Study to E

Project: Research project

Project Details

Description

VX14-661-110: A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment with VX-661 in Combination with Ivacaftor in Subjects Aged 12 Years and Older
StatusFinished
Effective start/end date10/5/1510/5/18

Funding

  • Vertex Pharmaceuticals Incorporated

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.